RNase A (10mg/mL, DNase free)
Based on 4 publication(s) in Google Scholar
RNase A (10mg/mL, DNase free) is a ribonuclease used to catalyze RNA degradation without containing DNase. RNase A is often employed in cell cycle assay.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) RNase A (10mg/mL, DNase free)
More-
WB
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Product Information Molecular weight: 13.7 kDa (monomer) Storage buffer: 50 mM Tris-HCl (pH 7.4), 50% (v/v) glycerol Instructions The recommended concentration of RNase A is 1-100 μg/mL.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
3.1.27.5
Chemical Information
-
Appearance Liquid
-
Color Colorless to light yellow
-
SMILES
[RNase A (10mg/mL, DNase free)]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (4)
-
Journal Impact Factor
-
Most Recent
-
Cell Death Dis
Sensing of endogenous retroviruses-derived RNA by ZBP1 triggers PANoptosis in DNA damage and contributes to toxic side effects of chemotherapy. [Abstract]2024 Oct 27;15(10):779. PMID: 39465258
RNase A (10mg/mL, DNase free) purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Oct 27;15(10):779. [Abstract]
Recombinant ZBP1-derived MDF cells were treated with ETO for 12 hours. After cell lysis, the cells were treated with DNase I or RNase A (1 mg/mL) for 1 hour, respectively. The cell lysates were then immunoprecipitated with FLAG antibody (IP:FLAG), and analyzed by Western blotting using the specified antibody.
-
Biomedicines
Adipose Stem Cell-Derived Apoptotic Vesicles Attenuate Hypertrophic Scarring by Targeting the CDC20/WNT Signaling Pathway. [Abstract]2026 May 11;14(5):1083. PMID: 42193410 -
Nitric Oxide
Catestatin alleviates PASMC phenotypic switching-mediated pulmonary arterial remodeling in a rat model of MCT-induced pulmonary arterial hypertension by promoting endothelium-derived no synthesis. [Abstract]2025 Oct:158:93-105. PMID: 40633831 -
Purity & Documentation
-
Data Sheet (268 KB)
-
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Korean - KR (419 KB)
- Portuguese - PT (419 KB)
-
Handling Instructions (2659 KB)
References
[1]. Raines R T. Ribonuclease a[J]. Chemical reviews, 1998, 98(3): 1045-1066.
[2]. Wang L, et al. The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer. Oncotarget. 2017 May 16;8(32):52877-52888. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)